SCHEMBL9685233

SCHEMBL9685233

Cc1cc(C(C)(C)C)c(Op2oc3ccccc3c3ccccc3o2)c(C(C)(C)C)c1

nearest known ligand 0.37

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.33
CA2 P00918 1/20 0.33
POLB P06746 1/20 0.33
TYR P14679 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12266789 0.93 ALDH1A1 (0.31) ALDH1A1CA2POLBTYRSMN1; SMN2
SCHEMBL15356799 0.85 CA1 (0.33) CA2TDP1
SCHEMBL13627008 0.85
SCHEMBL13627010 0.84 HNF4A (0.36) ALDH1A1CYP3A4TSHR
SCHEMBL130725 0.82 RXRA (0.33)
SCHEMBL29879856 0.82 RXRA (0.33)
SCHEMBL17280430 0.82 HSD17B10 (0.30)
SCHEMBL19754905 0.81
SCHEMBL14544160 0.81 ALDH1A1 (0.32) ALDH1A1TYRTSHRTDP1
SCHEMBL1389648 0.80 CA1 (0.36) ALDH1A1CA2SMN1; SMN2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414220-B1 PROCESSES FOR CONVERTING OLEFINS TO ALCOHOLS, ETHERS, OR COMBINATIONS THEREOF DOW TECHNOLOGY INVESTMENTS LLC (US) 2021-10-13 EP claimed
US-10766839-B2 Process for converting olefins to alcohols, ethers, or combinations thereof DOW TECHNOLOGY INVESTMENTS LLC (US) 2020-09-08 US claimed
US-20190047930-A1 PROCESS FOR CONVERTING OLEFINS TO ALCOHOLS, ETHERS, OR COMBINATIONS THEREOF UNION CARBIDE CORPORATION 2019-02-14 US claimed
EP-3414220-A1 PROCESSES FOR CONVERTING OLEFINS TO ALCOHOLS, ETHERS, OR COMBINATIONS THEREOF Dow Technology Investments LLC (US) 2018-12-19 EP claimed
WO-2017139543-A1 PROCESSES FOR CONVERTING OLEFINS TO ALCOHOLS, ETHERS, OR COMBINATIONS THEREOF DOW TECHNOLOGY INVESTMENTS LLC (US) 2017-08-17 WO claimed
EP-3414220-B1 PROCESSES FOR CONVERTING OLEFINS TO ALCOHOLS, ETHERS, OR COMBINATIONS THEREOF DOW TECHNOLOGY INVESTMENTS LLC (US) 2021-10-13 EP disclosed
US-10766839-B2 Process for converting olefins to alcohols, ethers, or combinations thereof DOW TECHNOLOGY INVESTMENTS LLC (US) 2020-09-08 US disclosed
US-20190047930-A1 PROCESS FOR CONVERTING OLEFINS TO ALCOHOLS, ETHERS, OR COMBINATIONS THEREOF UNION CARBIDE CORPORATION 2019-02-14 US disclosed
EP-3414220-A1 PROCESSES FOR CONVERTING OLEFINS TO ALCOHOLS, ETHERS, OR COMBINATIONS THEREOF Dow Technology Investments LLC (US) 2018-12-19 EP disclosed
WO-2017139543-A1 PROCESSES FOR CONVERTING OLEFINS TO ALCOHOLS, ETHERS, OR COMBINATIONS THEREOF DOW TECHNOLOGY INVESTMENTS LLC (US) 2017-08-17 WO disclosed
CN-1029774-C Rhodium complex hydrogen formylation catalyst and precursor composition of catalyst UNION CARBIDE CHEM PLASTIC (US) 1995-09-20 CN disclosed
EP-0155508-B1 TRANSITION METAL COMPLEX CATALYZED REACTIONS UNION CARBIDE CORPORATION (US) 1992-12-09 EP disclosed
US-4789753-A FORMYLATION CATALYST COMPLEX UNION CARBIDE CORPORATION (US) 1988-12-06 US disclosed
US-4737588-A CONTAINING DIORGANOPHOSPHITE-HYDROFORMYLATION CATALYST UNION CARBIDE CORPORATION (US) 1988-04-12 US disclosed
US-4717775-A RHODIUM-DIORGANOPHOSPHITE COMPLEX CATALYZED HYDROFORMYLATION REACTIONS UNION CARBIDE CORPORATION (US) 1988-01-05 US disclosed
US-4599206-A Transition metal complex catalyzed reactions UNION CARBIDE CORPORATION (US) 1986-07-08 US disclosed
EP-0155508-A1 Transition metal complex catalyzed reactions UNION CARBIDE CORPORATION (US) 1985-09-25 EP disclosed
WO-1985003702-A1 TRANSITION METAL COMPLEX CATALYZED REACTIONS UNION CARBIDE CORPORATION (US) 1985-08-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190047930-A1 PROCESS FOR CONVERTING OLEFINS TO ALCOHOLS, ETHERS, OR COMBINATIONS THEREOF ADH1C, ADH1A, ADH5 ALDH1A1 77/4885CA2 2730/4885POLB 593/4885
US-10766839-B2 Process for converting olefins to alcohols, ethers, or combinations thereof ADH1C, ADH1A, ADH5 ALDH1A1 99/4885CA2 2750/4885POLB 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.